 IDEAYA Biosciences NASDAQ:IDYA was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued to investors on Wednesday, Zacks.com reports. The brokerage currently has a 16.00 price objective on the stock. Zacks Investment Researchs price objective points to a potential upside of 12.91 from the companys previous ... 